Finance

Lists
Why is TPST down 3.86%?
Dive Deeper
TPST:NASDAQ
Tempest Therapeutics Inc
$0.60
-3.86%
(-0.024) 1D
$0.60
+0.78% (+0.0047)
After hours
Closed: Oct 19, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TPST...
Open
$0.64
High
$0.64
Low
$0.60
Mkt. cap
10.20M
Avg. vol.
5.25M
Volume
128.47K
52-wk high
$11.13
52-wk low
$0.60
EPS
-$4.49
Beta
-1.73
Shares outstanding
16.89M
No. of employees
4
Open
$0.64
High
$0.64
Low
$0.60
Mkt. cap
10.20M
Avg. vol.
5.25M
Volume
128.47K
52-wk high
$11.13
52-wk low
$0.60
EPS
-$4.49
Beta
-1.73
Shares outstanding
16.89M
No. of employees
4
News stories
From web sources and news partners
About Tempest Therapeutics Inc
CEOStephen R. Brady
Employees4
Founded2011
HeadquartersBrisbane, California, United States
SectorBiotechnology
Websitetempesttx.com
Analyst ratings
Based on 1 analyst giving stock ratings to TPST in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for TPST in the last 3 months
Highest
Current $0.60
$7.00 (+1,066.47%)
Average
$7.00 (+1,066.47%)
Lowest
$7.00 (+1,066.47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
$7.00
+1,066.5%
09/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
570.00K
539.00K
114.00K
1.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.03M
3.54M
5.42M
3.43M
Operating expense
3.60M
4.08M
5.54M
5.25M
Total operating expenses
3.60M
4.08M
5.54M
5.25M
Operating income
-3.60M
-4.08M
-5.54M
-5.25M
Other non operating income
-
-
-
-
EBT including unusual items
-3.51M
-4.02M
-27.70M
-5.24M
EBT excluding unusual items
-3.51M
-4.02M
-5.52M
-5.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.51M
-4.02M
-27.70M
-5.24M
Net profit margin
-
-
-
-
Earnings per share
-0.79
-0.62
-0.50
-0.34
Interest and investment income
86.00K
56.00K
23.00K
6.00K
Interest expense
-
-
-
-
Net interest expenses
86.00K
56.00K
23.00K
6.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.53M
-4.01M
-5.48M
-5.19M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps